• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number UNK CDS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Atrial Fibrillation (1729); Mitral Valve Stenosis (1965); Renal Failure (2041); Sepsis (2067); Heart Failure/Congestive Heart Failure (4446); Gastrointestinal Hemorrhage (4476)
Event Date 05/01/2014
Event Type  Death  
Manufacturer Narrative
The devices will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Death date, event date, and implant date: dates estimated.The udi number is not known as the part and lot number were not provided.The additional serious injury and malfunction reported in the article are captured under a separate medwatch report number.Article titled, "mitral valve surgery for persistent or recurrent mitral regurgitation after transcatheter edge-to-edge repair is associated with improved survival.".
 
Event Description
This research article was a retrospective study designed to highlight the potential of surgery as an option for high-risk patients who underwent transcatheter edge-to-edge repair and developed recurrent mitral regurgitation.Complications identified in the study included: single leaflet device attachment, difficult to remove, worsening mr, severe mitral stenosis, mitral valve replacement, gastrointestinal bleeding, sepsis, renal failure, postoperative atrial fibrillation, stroke, prolonged hospitalization due to heart failure, death.In conclusion surgical treatment of severe mr after mitral teer is feasible but requires mitral valve replacement.Compared with medical therapy, mitral surgery is associated with significantly lower risk-adjusted all-cause mortality during midterm follow-up.Details are listed in the attached article titled "mitral valve surgery for persistent or recurrent mitral regurgitation after transcatheter edge-to-edge repair is associated with improved survival".
 
Manufacturer Narrative
The device was not returned for analysis.The lot history record (lhr) review was not performed because this incident was based on an article review and no lot information was provided.Additionally, the complaint history review was not performed because this incident was based on an article review and no lot information was provided.Based on available information, the cause of the reported mitral valve insufficiency/ regurgitation (worsening mr), mitral stenosis, hemorrhage (blood transfusion), sepsis, renal failure, atrial fibrillation, cerebrovascular accident, unrelated death, and heart failure/congestive heart failure (prolonged hospitalization) could not be determined.The cause of the reported incomplete coaptation could not be determined.The reported patient effects of mitral regurgitation, atrial fibrillation, sepsis, mitral stenosis, hemorrhage, renal failure, cerebrovascular accident, death, and heart failure, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported surgical intervention, hospitalization, and unexpected medical intervention were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.B2, b3, d6: dates estimated d4: the udi number is not known as the part and lot number were not provided the additional serious injury and malfunction reported in the article are captured under a separate medwatch report number.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key15885740
MDR Text Key304542236
Report Number2135147-2022-02264
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK CDS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/08/2022
Initial Date FDA Received11/30/2022
Supplement Dates Manufacturer Received12/16/2022
Supplement Dates FDA Received01/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age75 YR
Patient SexMale
-
-